Frovatriptan as a Transitional Therapy in Medication Overuse Headache

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by University of Calgary
Sponsor:
Collaborator:
AHS Cancer Control Alberta
Information provided by (Responsible Party):
Farnaz Amoozegar, University of Calgary
ClinicalTrials.gov Identifier:
NCT01044251
First received: January 5, 2010
Last updated: December 10, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)